IMB-26

• UNSPSC Description:

  IMB-26 is a HCV inhibitor with an EC50 of 2.1 μM. IMB-26 shows potent an anti-HCV activity[1].

• Target Antigen:

  HCV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/imb-26.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC1=CC(OC)=C(OC)C(OC)=C1)C2=CC=C(OC)C(NC(C(Br)C)=O)=C2

• Molecular Weight:

  467.31

• References & Citations:

  [1]Yonghua Liu, et al. Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus. Eur J Med Chem. 2022 Jan 15;228:114033.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1001426-49-8